Curavit Clinical Research Corp — Form D/A
Curavit Clinical Research Corp of SCARSDALE, NY, a company, filed a Form D amendment with the SEC on 2024-09-05. The offering totals $11.6M, of which $11.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-09-05
- Form: D/A
- Accession: 0001947723-24-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $11.6M
- Amount sold: $11.4M
- Remaining: $220K
- Investors: 30
- Date of first sale: 2022-09-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-461679
Issuer
- Name: Curavit Clinical Research Corp
- CIK: 0001947723
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 18 LARCH LANE, SCARSDALE, NY, 10583
- Phone: 917-885-0024
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| David Hanaman | Director | Scarsdale, NY |
| Jackie Kent | Director | Scarsdale, NY |
| Nathanael Lentz | Director | Spokane, WA |
| Rich Lester | Director | Scarsdale, NY |
| Joel Morse | Director | Scarsdale, NY |
| Joel Morse | Executive Officer | Scarsdale, NY |
Other filings by this issuer (2)
More